Kinnate Biopharma Announces Pricing of Initial Public Offering
02 déc. 2020 22h02 HE
|
Kinnate Biopharma
SAN FRANCISCO and SAN DIEGO, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small...